New real-world study reveals oral corticosteroid overuse in patients with chronic rhinosinusitis with nasal polyps Français
According to the ACTIONS study, 39% of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) faced overexposure to oral corticosteroids (OCS) before beginning biologic therapy.
ACTIONS was carried out by GSK in collaboration with Asthma Canada and leading Canadian Rhinologists.
MISSISSAUGA, ON, June 10, 2025 /CNW/ - A new Canadian real-world study, ACTIONS (chAracterizing oral Corticosteroid use in patients with chronic rhInOsinusitis with Nasal polypS in Canada), revealed patterns of oral corticosteroid (OCS) use among patients with chronic rhinosinusitis with nasal polyps (CRSwNP) prior to starting biologic treatments. The full findings were recently presented at the Canadian Society of Otolaryngology Head and Neck Surgery Annual Meeting in Fredericton, New Brunswick.
The study findings revealed that 81% of CRSwNP patients were prescribed OCS at least once in the 24 months prior to starting a biologic treatment with 39% of patients being overexposed to OCS by the time they started a biologic. These findings highlight the need for heightened awareness and education to prevent OCS overexposure and enhance patient care.
CRSwNP is a chronic inflammatory disease of the paranasal sinuses and nasal mucosa leading to the growth of nasal polyps; 1 CRSwNP is associated with significant disease burden which negatively affects patients' quality of life. 2 Treatment for CRSwNP involves a combination of medical and surgical interventions. OCS are a common and effective medical treatment option for patients with CRSwNP, often used alongside nasal saline irrigation for short-term control of symptoms. 3 Despite their proven short-term efficacy, OCS are also associated with increased risk of short- and long-term adverse effects, with guidelines in respiratory disease recommending limiting use when possible. 4,5
Biologics have emerged as a newer treatment option with demonstrated effectiveness in managing CRSwNP, including decreasing the dependence on OCS. 6-8 The ACTIONS study revealed critical patterns of OCS use among CRSwNP patients, underscoring a significant unmet need that healthcare professionals should address.
ACTIONS was conducted by GSK and Asthma Canada in collaboration with Dr. Yvonne Chan from the University of Toronto, Dr. Marie-Noëlle Corriveau from Université Laval, and Dr. Andrew Thamboo from the University of British Columbia, with research support, input, and analytics provided by IQVIA Solutions Canada Inc.
"Our findings indicate that a significant proportion of severe CRSwNP patients are at risk of OCS overexposure. By considering earlier biologic initiation, when indicated, we can potentially reduce this risk and improve patient outcomes. Furthermore, collaboration among healthcare providers to promote awareness and adherence to these protocols will be vital in transforming patient care," said Dr. Marie-Noëlle Corriveau.
"The data clearly indicate that a proactive strategy involving earlier biologic therapy can play a pivotal role in managing CRSwNP more efficiently. Embracing these new approaches is not just beneficial, but essential for improving the quality of life for our patients," said Dr. Yvonne Chan.
"CRSwNP and asthma often coexist, share underlying mechanisms and influence each other's severity and management. This study is a critical step forward in understanding the treatment landscape for CRSwNP. It shows how vital it is to reduce our dependence on OCS and to find more sustainable and effective treatments. Ultimately, this could mean better health and quality of life for patients," said Jeffrey Beach, President & CEO, Asthma Canada.
"As a leader in respiratory health, GSK remains committed to be at the forefront of the fight against respiratory disease. The ACTIONS study further underscores this dedication by providing valuable insights, fostering scientific and research excellence, and driving innovation," added Dr. Michelle Horn, Country Medical Director, GSK Canada.
About CRSwNP
CRSwNP is caused by inflammation of the nasal lining that can lead to soft tissue growths, known as nasal polyps. 3,6 People with CRSwNP experience symptoms such as nasal obstruction, loss of smell, facial pain, sleep disturbance, infections and nasal discharge that can significantly affect their emotional and physical well-being. 1,6,10-11 IL-5 is a key cytokine (protein) in type 2 inflammation characterized by eosinophils (a type of white blood cell), which is present in up to 85% of people with CRSwNP. 1,6,10,11 IL-5 and eosinophils are frequently found in high concentrations in sinus and nasal polyp tissue of patients with CRSwNP and are associated with more severe disease. 13-19
About OCS
Oral corticosteroids (OCS) are systemic anti-inflammatory medications used to manage inflammatory conditions, including respiratory diseases, and allergic reactions. Unlike inhaled corticosteroids (ICS), which target the lungs directly, and intranasal corticosteroids (INCS) which target the nasal airways, OCS are ingested and distributed throughout the body. Common types include prednisone, methylprednisolone, and hydrocortisone. The use of OCS, including in repeated short bursts, can lead to significant health risks. The wide range of adverse effects associated with OCS include increased risk of infection and cardiovascular events, osteoporosis, type 2 diabetes mellitus, weight gain, and mood and behaviour disturbances. 20 In the ACTIONS study, overexposure to OCS is defined as total yearly dose of OCS ≥1,000 mg given that the risk of adverse effects significantly increases once a patient receives a cumulative lifetime exposure of 1000mg of OCS. 20
About GSK in respiratory
GSK continues to build on decades of pioneering work to deliver more ambitious treatment goals, develop the next generation standard of care, and redefine the future of respiratory medicine for hundreds of millions of people with respiratory diseases. With an industry-leading respiratory portfolio and pipeline of vaccines, targeted biologics and inhaled medicines, we are focused on improving outcomes and the lives of people living with all types of asthma and COPD along with less understood refractory chronic cough or rarer conditions like systemic sclerosis with interstitial lung disease. GSK is harnessing the latest science and technology with the aim of modifying the underlying disease dysfunction and preventing progression.
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.ca.
References
SOURCE GlaxoSmithKline Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
an hour ago
- Cision Canada
New Book Addresses Mental Health Crisis Among Men with Honest, Practical Approach
"Mental Health for Men: Daily Reminders to Stop Being So Hard On Yourself" Offers Real Solutions for Modern Masculine Challenges VANCOUVER, BC, June 11, 2025 /CNW/ - Author James R.C. Smith releases his groundbreaking new book, " Mental Health for Men: Daily Reminders to Stop Being So Hard on Yourself," addressing the largely overlooked mental health crisis affecting millions of men worldwide. Available now on Amazon, this 86-page fillable journal and handbook offers a no-nonsense approach to male mental wellness that breaks through traditional barriers and outdated expectations. The Silent Struggle The statistics are sobering: nearly one in three men experience moderate to high anxiety, and one in five face depression, yet men remain the demographic least likely to seek help or discuss their mental health openly. Smith's book directly confronts this crisis, offering practical tools and honest insights for men exhausted by society's impossible standards. "We've been handed an outdated manual that tells us never to show weakness, figure it out ourselves, and just 'man up,'" says Smith. "But how's that working out for us? The strongest thing you can do as a man is ask for help. Just because you CAN do it alone doesn't mean you SHOULD." A Different Kind of Self-Help Unlike traditional self-help books that promise transformation into a "zen master," Smith's approach is refreshingly realistic. The book acknowledges the unique challenges modern men face—from remote work pressures to digital parenting demands, constant connectivity, and the impossible expectation to be both traditionally masculine and emotionally available. The handbook includes: Research-backed strategies that fit into busy lifestyles Cognitive behavioral therapy techniques presented in accessible language Permission-giving exercises for imperfection in work, parenting, and relationships Practical guidance on asking for help without feeling like a failure Honest reflection exercises from someone who's "been there" Breaking the Stigma "Your mental health isn't a luxury—it's essential," Smith emphasizes. "And taking care of it isn't soft—it's as crucial as changing your oil, eating your veggies, or getting enough sleep." The book's direct, unfiltered tone resonates with men who are tired of being told to suppress their struggles while simultaneously being expected to be emotionally available. Smith's approach combines vulnerability with practicality, offering tools that actually work for real men living real lives. About the Author brings personal experience and research-backed insights to the conversation about men's mental health. Writing from the perspective of someone who has faced the same challenges as his readers, Smith offers authentic guidance rather than distant expertise. Availability "Mental Health for Men: Daily Reminders to Stop Being So Hard on Yourself" is available now on Amazon in hardcover format. The book features 86 pages of practical content designed for busy men who need real solutions, not empty promises. Book Details: Title: Mental Health for Men: Daily Reminders to Stop Being So Hard On Yourself Author: James R.C. Smith Publisher: IngramSpark Publication Date: June 6, 2025 Format: Hardcover, 86 pages ISBN-13: 978-1069562708 Available: Amazon and other major retailers
Toronto Star
2 hours ago
- Toronto Star
Carney government balancing AI regulation against the promise to unlock its potential
OTTAWA—Prime Minister Mark Carney believes artificial intelligence is key to unlocking Canada's economic potential. He carved out a specific ministry for the file, installing former broadcaster Evan Solomon as the country's first-ever minister of AI. The 'transformative nature' of the technology garnered a mention in the sole mandate letter he issued for his cabinet. ARTICLE CONTINUES BELOW Capitalizing on the use of AI is one of Carney's three 'core missions' as he prepares to host next week's G7 leaders' summit. Yet among the nascent Liberal government's ambitious promises to return Canada to its position as a global AI leader, promote the widespread adoption of the technology, and invest in the infrastructure needed to do so, there are no concrete pledges to regulate the sprawling uses of the rapidly evolving tools. 'AI is a fundamentally transformative technology and has the capacity to change the way we do almost everything. So I see this as just a point in history where we are transforming the way our markets work, the way our societies work, and we want that to be good,' said Gillian Hadfield, a professor of AI alignment and governance at Johns Hopkins University, and former member of the Canadian AI Advisory Council. 'When I look around the world, I see governments that have not really figured out: 'What do we need to do in the legal and regulatory space to manage this transition well?'' On Tuesday, Solomon danced around the issue of regulation, noting the difficulties of spurring AI development while also ensuring the technology is deployed responsibly. 'It's easy for editorials to write: 'Just find the right balance. Don't be so unconstrained as the U.S. and China, who see any regulation as a constraint on security or innovation. But don't be too overly protective like Europe,'' Solomon said at a Canada 2020 conference in Ottawa. ARTICLE CONTINUES BELOW ARTICLE CONTINUES BELOW 'OK. Perfect. Easy. Throw the dart, blindfolded, after six beers.' What Solomon did suggest is that the Carney government will distance itself from the previous Liberal government's appetite for imposing regulations. 'We are moving from our back foot of just warning and overindexing on warnings and regulation, to our front foot, to make sure that the Canadian economy and all Canadians benefit from … using this technology productively,' he said. Carney has pushed for advancing AI in myriad ways, from pledging to build data centres, proposing tax credits that would incentivize businesses to adopt the technology, and using it to improve government efficiency. But his government has not addressed what will happen to the Artificial Intelligence and Data Act (AIDA), which was folded into a larger bill aimed at updating privacy laws and creating a regulatory framework for AI. The bill never became law due to the suspension of Parliament earlier this year and the triggering of a snap spring election. The act was a particularly contentious prong of the proposed legislation, with critics blasting the act for concentrating too much power in unwritten regulations, concerns that having the same ministry simultaneously regulate and champion AI would introduce conflicts, and a lack of clarity on what AI systems it would apply to and what kinds of harms the legislation would minimize. But some experts urged the government to swiftly pass the legislation, warning that Canada was falling 'out of sync' with the uncontrollable pace at which technology was being used. ARTICLE CONTINUES BELOW ARTICLE CONTINUES BELOW Solomon referenced the bill Tuesday, saying he wouldn't 'abandon regulation,' but that Canada will need to 're-examine, in this new environment, where we're going to be on that.' Ignacio Cofone, a professor of AI regulation at the University of Oxford and former Canada research chair in data governance at McGill University, told the Star in an email that it was critical that Canada move forward with an improved version of the act. 'AI systems already shape decisions in consequential areas as diverse as housing, employment, health care, and criminal justice, often in opaque and unaccountable ways,' Cofone wrote, adding that industry, which has 'incentives to prioritize profit' should not be left to regulate itself. Two former senior government officials with knowledge of the previous government's AI strategy told the Star, on the condition they not be named, that they believe the Carney government will take a more hands-off approach. One source said they believed that Carney is likely wary of the 'political mess' the Trudeau government found itself in as it crafted its legislation. 'Every day Canada doesn't advance its own responsible use policies or regulatory frameworks, we are just going to be further and further behind,' the source said. ARTICLE CONTINUES BELOW ARTICLE CONTINUES BELOW Another source said that while they agreed that Canada cannot 'overregulate' the industry, particularly in the face of unprecedented trade disputes with the U.S., 'it shouldn't be controversial to say that we need to enshrine rights for Canadians against some of these uses.' Teresa Scassa, a Canada research chair in information law and policy at the University of Ottawa, said Canada appears to be stuck between Europe — which last year passed the world's first AI regulation law — and the U.S., which has dismantled efforts to address the risks of the technology. Scassa said a Canadian AI regulation law could be leveraged in the country's trading relationship with the EU, potentially allowing Canadian companies to do business in Europe. 'On the other hand, we have a government south of the border that sees everything through a trade lens. And if Canada has strong AI regulation or even weak AI regulation, that could be seen as a trade irritant,' Scassa said. But Hadfield said the government should not be looking at innovation and regulation as mutually exclusive objectives. 'Our economies are built on good, reliable, legal infrastructure. And if the economy is changing so rapidly with this very different technology … then we absolutely need to be thinking very hard about governance,' Hadfield said. Politics Headlines Newsletter Get the latest news and unmatched insights in your inbox every evening Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. Please enter a valid email address. Sign Up Yes, I'd also like to receive customized content suggestions and promotional messages from the Star. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Politics Headlines Newsletter You're signed up! You'll start getting Politics Headlines in your inbox soon. Want more of the latest from us? Sign up for more at our newsletter page.
Global News
2 hours ago
- Global News
Cost of living has half of Canadian pet owners skipping vet visits: survey
Half of Canadian pet owners are skipping visits to the veterinarian's office because of financial concerns, a new survey shows. According to a survey conducted by PetSmart Charities of Canada and Gallup, half (50 per cent) of Canadian pet parents have either skipped or declined necessary veterinary care for their pets. Financial pressure was the leading cause of people skipping the vet's office, the survey of 2,033 dog and cat owners from the 10 provinces in Canada found. Of those who said they were declining or skipping those visits, 67 per cent said they did so because it was not affordable, they did not believe the services were worth the cost or a combination of both. 0:59 Global Okanagan Adopt A Pet: Diesel The rate of pet parents skipping the vet was higher among younger Canadians (59 per cent). Story continues below advertisement Even higher-income Canadians were facing financial pressures in dealing with pet care, with 27 per cent of pet owners who make more than $90,000 a year saying they have skipped vet visits. Get daily National news Get the day's top news, political, economic, and current affairs headlines, delivered to your inbox once a day. Sign up for daily National newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy Of the Canadians who declined pet care, 21 per cent said their veterinarian offered them a payment plan and 66 per cent said an interest-free plan could double what they are able to spend on life-saving care for their furry friends. Another major reason for Canadians skipping pet care is that their vet is simply too far away. Just under half (46 per cent) of those who travel under 10 kilometres to the veterinarian report skipping or declining care, but that figure rises to 54 per cent for those who travel more than 10 kilometres. 2:48 Global Peterborough's Shelter Pet Project June 6 Nearly one in five (18 per cent) pet owners said they rely on non-vets when their pet is sick. This includes consulting the internet, friends or pet professionals, such as trainers and groomers. Story continues below advertisement Four in 10 pet owners said they would be open to services like telemedicine or home visits by vets. 'These data suggest that services like community clinics and telemedicine — where permitted and available — could help make care more accessible, and many pet parents would use them if they could. But awareness and regulation of these services still vary across regions, pointing to opportunities for expanded infrastructure and support,' said Julie Ray, Gallup's managing editor for world news. A recent Ipsos poll showed that inflation and cost of living was the top issue for Canadians. That issue was considered the top domestic news story in Canada by 71 per cent of Canadians, according to the polling conducted exclusively for Global News on what people considered the biggest stories of this year. 4:44 Adopt a Pet: New Hope Dog Rescue fostering dogs for wildfire evacuees Results for the PetSmart Charities of Canada-Gallup State of Pet Care study are based on a combined web- and phone-based survey conducted with 2,033 dog and cat owners from the 10 provinces in Canada. Gallup surveyed 1,804 Canadian adults who indicated they currently owned at least one dog or cat via a web-based survey Nov. 28-Dec. 31, 2024. Gallup also surveyed an additional 229 dog and cat owners via a telephone survey Dec. 5-23, 2024, to reach pet owners who may not have access to the internet. For results based on the total sample of 2,033 Canadian dog and cat owners, the margin of sampling error is ±2.3 percentage points at the 95 per cent confidence level. Margins of error for subgroups are larger.
